The ills of diabetes are to be fought for a long time, a medical condition in which the blood glucose, blood sugar levels in the body is too high. There is also a routine process of getting the required insulin to curb these levels. The insulin is available in the major diagnostic labs in Delhi. It is estimated that as many as 40% of people diagnosed with type 1 diabetes may also have another autoimmune condition, like celiac disease or thyroid disease. Notably, antibody screening offers an effective way to screen for various autoimmune conditions, including type-1 diabetes. Most recently, researchers developed a new test that can screen for four autoimmune conditions simultaneously. This feat has been achieved by the researchers of the University of Colorado. This endeavor had the backing in the form of grants offered by the Juvenile Diabetes Research Foundation (JDRF) and the National Institutes of Health (NIH). The authors reported no financial conflicts of interest related to this work. The scientists published the results of their research in the most recent issue of The Lancet, a weekly peer-reviewed general medical journal.
What may be termed as the biggest breakthrough, the newly-developed test combines seven different antibodies to screen for four autoimmune conditions: type 1 diabetes, celiac disease, thyroid disease, and autoimmune poly-glandular syndrome-1 (APS-1). The study authors reported that in testing the new assay, they found “high sensitivity and disease specificity, along with high throughput and low cost for large scale screenings in the general population.”
This research constitutes a very important step in proactive screening and detection of related autoimmune diseases. Early detection and appropriate treatment of autoimmune diseases can translate to fewer health complications and a higher quality of life for patients. Early detection of disease is especially critical for conditions that are life-threatening, such as type 1 diabetes and APS-1.
The researchers made the following conclusions about their stupendous work in the publication:
This is the first validated multiplexed autoantibody assay, which is feasible and ready to be used in clinical trials for large-scale population screenings…to simultaneously screen for type-1 diabetes and multiple relevant autoimmune diseases associated with auto antibodies. This multiplexed autoantibody assay has been extensively validated and provides a great tool for general population screening with high efficiency, low cost, and small sample amount. We anticipate these multiplexed assays will become available in clinics and easily applied to large population screening in the near future.
It appears likely that this test will soon offer an effective means of screening at-risk individuals for associated autoimmune conditions, and can help facilitate early and accurate detection of several life-threatening diseases with a single test.
Thus we can say that this rapid stride taken to screen and analyze the various forms of diabetes shall go a long way in providing the most comprehensive report for diabetes. This can further enhance the process of recovery and maintaining lifestyle which is based on scientific approach and choices without any health complications.